These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4268763)

  • 41. Dose-Response curves for tubocurarine, alcuronium and pancuronium.
    Lund I; Stovner J
    Acta Anaesthesiol Scand Suppl; 1969; 37():238-42. PubMed ID: 4246294
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical study of pancuronium as muscle relaxant in anesthesia.
    Park WY; Macnamara TE
    Anesth Analg; 1973; 52(4):502-7. PubMed ID: 4123904
    [No Abstract]   [Full Text] [Related]  

  • 43. Pancuronium bromide: a review of its pharmacological properties and clinical application.
    Speight TM; Avery GS
    Drugs; 1972; 4(3):163-226. PubMed ID: 4264763
    [No Abstract]   [Full Text] [Related]  

  • 44. [Sedative therapy in tetanus].
    Di Nola F; Soranzo ML
    Minerva Med; 1973 Jan; 64(4):181-4. PubMed ID: 4265608
    [No Abstract]   [Full Text] [Related]  

  • 45. Fade characteristics and onset times following administration of pancuronium, tubocurarine and a mixture of both agents.
    Cashman JN; Jones RM; Vella LM
    Br J Anaesth; 1985 May; 57(5):488-92. PubMed ID: 3994882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Porcine malignant hyperthemia IV: Neuromuscular blockade.
    Hall GM; Lucke JN; Lister D
    Br J Anaesth; 1976 Dec; 48(12):1135-41. PubMed ID: 1023949
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of magnesium sulphate on urinary catecholamine excretion in severe tetanus.
    Thwaites CL; Yen LM; Cordon SM; Thwaites GE; Loan HT; Thuy TT; White NJ; Soni N; Macdonald IA; Farrar JJ
    Anaesthesia; 2008 Jul; 63(7):719-25. PubMed ID: 18582257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of pipecuronium with pancuronium on haemodynamic variables and plasma catecholamines in coronary artery bypass patients.
    Neidhart PP; Champion P; Vogel J; Zsigmond EK; Tassonyi E
    Can J Anaesth; 1994 Jun; 41(6):469-74. PubMed ID: 8069985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of the sympatholytic pirroxan on catecholamine excretion in experimental tetanus].
    Aleksevich IaI; Kun ND
    Farmakol Toksikol; 1981; 44(1):115-7. PubMed ID: 7262293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparative study between pancuronium bromide and d-tubocurarine].
    Costa PN
    Rev Bras Anestesiol; 1971; 21(4):721-7. PubMed ID: 4259786
    [No Abstract]   [Full Text] [Related]  

  • 51. Proceedings: Neuromuscular blocking drugs in porcine malignant hyperthermia.
    Hall GM; Lucke JN; Lister D
    Br J Anaesth; 1976 Mar; 48(3):270-1. PubMed ID: 1259903
    [No Abstract]   [Full Text] [Related]  

  • 52. [Pancuronium bromide--a new non-depolarizing muscle relaxant].
    Kok OV; de Bruyn TB; Sevenster Gv; de Kock MJ; Lawrance WH; Badenhorst SJ
    S Afr Med J; 1969 Dec; 43(48):1459-61. PubMed ID: 4190216
    [No Abstract]   [Full Text] [Related]  

  • 53. Side effects and changes in pulmonary function after fixed dose precurarization with alcuronium, pancuronium or vecuronium.
    Motsch J; Fuchs W; Hoch P; Kaas V; Hutschenreuter K
    Br J Anaesth; 1987 Dec; 59(12):1528-32. PubMed ID: 2892518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical experience with a new muscle relaxant, pancuronium bromide].
    Shiratsuchi T; Baba H; Matsuyama K; Yamamoto T
    Masui; 1970 Jul; 19(7):805-9. PubMed ID: 4247412
    [No Abstract]   [Full Text] [Related]  

  • 55. Treating severe tetanus with muscle paralysis and intermittent positive pressure ventilation.
    Sykes K
    Eur J Anaesthesiol; 1998 May; 15(3):380. PubMed ID: 9650004
    [No Abstract]   [Full Text] [Related]  

  • 56. Waiting time after non-depolarizing relaxants alter muscle fasciculation response to succinylcholine.
    Pinchak AC; Smith CE; Shepard LS; Patterson L
    Can J Anaesth; 1994 Mar; 41(3):206-12. PubMed ID: 7910525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Experimental and clinical study of the effects of pancuronium bromide, a neuromuscular blocking agent.
    Manani G; Galzigna L; Mammano S; Gasparetto A
    Arzneimittelforschung; 1972 Sep; 22(9):1528-34. PubMed ID: 4264758
    [No Abstract]   [Full Text] [Related]  

  • 58. [Relaxograph monitoring of severe tetanus treated with muscle relaxants].
    Tchoua R; Bensousan T
    Ann Fr Anesth Reanim; 1992; 11(6):727. PubMed ID: 1300079
    [No Abstract]   [Full Text] [Related]  

  • 59. Cost-effective treatment of atracurium resistance in critically ill patients.
    Tschida SJ; Hoey LL; Vance-Bryan K
    Am J Health Syst Pharm; 1995 Aug; 52(16):1818-9. PubMed ID: 8528843
    [No Abstract]   [Full Text] [Related]  

  • 60. [Physiopathology and treatment of tetanus. 2].
    Benabderrahmane M
    Schweiz Rundsch Med Prax; 1973 Dec; 62(50):1545-55. PubMed ID: 4272465
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.